Hey worthind, I like your thinking on the Tibotec deal.... I pulled this from the independent report released early in Feb of this year (the same report that valued Avexa's pipeline other than ATC at $0 to $3mill), which by the reports admission was undervaluing the worth of Avexa's pipeline.
"Payments under licensing deals involving HIV drug programs
Oct 2006 Merck & Co Ambrilia Pre-Clinical $US229.0m Sep 2006 Bristol-Myers Medivir Pre-Clinical $US104.5m
Both these are upfront and milestone payments only. Excluding royalties "
If Avexa can get something close to this for their Integrase deal it will be happy days for all.
Joe
AVX Price at posting:
17.5¢ Sentiment: LT Buy Disclosure: Held
